SCHEMBL5794137

SCHEMBL5794137

Cc1sc(NC(=O)c2ccco2)c(C(N)=O)c1C

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 13/20 0.78
▸ MAPT P10636 9/20 0.78
▸ RAB9A P51151 9/20 0.78
▸ NPC1 O15118 8/20 0.78
▸ KMT2A Q03164 7/20 0.78
▸ MEN1 O00255 6/20 0.78
▸ KDM4E B2RXH2 8/20 0.75
▸ SMN1; SMN2 Q16637 8/20 0.75
▸ HSD17B10 Q99714 2/20 0.75
▸ CASP1 P29466 2/20 0.75
▸ TSHR P16473 1/20 0.75
▸ L3MBTL1 Q9Y468 1/20 0.75
▸ HPGD P15428 6/20 0.71
▸ CACNA1B Q00975 1/20 0.71
▸ APBA1 Q02410 1/20 0.71
▸ LMNA P02545 2/20 0.70
▸ FLT3 P36888 1/20 0.60
▸ TP53 P04637 4/20 0.60
▸ MAPK10 P53779 2/20 0.60
▸ NPSR1 Q6W5P4 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15731000 0.78 ALDH1A1 (0.76) ALDH1A1MAPTRAB9ANPC1KMT2A
SCHEMBL7003934 0.76 ALDH1A1 (0.70) ALDH1A1MAPTRAB9ANPC1KMT2A
SCHEMBL8290734 0.75 HPGD (1.00) ALDH1A1MAPTRAB9ANPC1KMT2A
SCHEMBL5453296 0.75 FLT3 (1.00) ALDH1A1MAPTRAB9ANPC1KMT2A
SCHEMBL7004914 0.75 NPC1 (0.61) ALDH1A1MAPTRAB9ANPC1KMT2A
SCHEMBL8288650 0.74 ALDH1A1 (0.68) ALDH1A1MAPTRAB9ANPC1KMT2A
SCHEMBL6996786 0.74 FLT3 (0.70) ALDH1A1MAPTRAB9ANPC1KMT2A
SCHEMBL6997315 0.73 ALDH1A1 (0.60) ALDH1A1MAPTRAB9ANPC1KMT2A
SCHEMBL5460090 0.72 ALDH1A1 (0.74) ALDH1A1MAPTRAB9ANPC1KMT2A
SCHEMBL7902809 0.72 GRIN2C (1.00) ALDH1A1MAPTRAB9ANPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006026619-A3 INHIBITION OF VIRUSES USING RNASE H INHIBITORS US HEALTH (US) 2006-05-04 — — WO disclosed
WO-2006026619-A2 INHIBITION OF VIRUSES USING RNASE H INHIBITORS GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2006-03-09 — — WO disclosed
Send feedback